Wuhan Yzy Biopharma Co., Ltd.
Clinical trials sponsored by Wuhan Yzy Biopharma Co., Ltd., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New antibody drug targets Cancer-Related fluid in the lungs Results expected Sep 2026 (estimated)